
Welcome to
ONLiNE UPSC
Schedule M is a vital section of the Drugs and Cosmetics Act of 1940 that establishes Good Manufacturing Practices (GMP) for the pharmaceutical industry in India. Its primary aim is to set standards that manufacturers must adhere to in order to ensure the quality, safety, and efficacy of their pharmaceutical products.
Schedule M outlines several critical components that pharmaceutical manufacturers must follow:
In 2005, an amendment was made to expand the section to include “Requirements of Premises, Plant, and Equipment for Pharmaceutical Products.” Most recently, in July 2023, the Ministry of Health and Family Welfare announced that the implementation of Schedule M would be mandatory for Micro, Small, and Medium Enterprises (MSMEs) in the pharma sector, to be executed in a phased manner.
Schedule M plays an integral role in ensuring that pharmaceutical products manufactured in India adhere to high standards of quality and safety. These regulations are crucial for maintaining the credibility of the health sector and fostering public trust, particularly in a market as vast and diverse as India’s.
Q1. What is the purpose of Schedule M in the pharmaceutical industry?
Answer: Schedule M establishes Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of pharmaceutical products manufactured in India.
Q2. What are the key components of Schedule M?
Answer: Key components include facility requirements, personnel guidelines, manufacturing control, storage and transport, documentation procedures, quality control, and equipment cleaning protocols.
Q3. When was Schedule M last updated?
Answer: Schedule M was last updated in July 2023, when it was made mandatory for MSMEs in the pharmaceutical sector to comply with its guidelines.
Q4. Why is compliance with Schedule M important?
Answer: Compliance with Schedule M is crucial to ensure the safety and quality of pharmaceutical products, which directly impacts public health and trust in the healthcare system.
Q5. What are the consequences of not following Schedule M?
Answer: Failure to adhere to Schedule M can result in regulatory penalties, product recalls, and loss of credibility, ultimately affecting public health and safety.
Question 1: What is the main aim of Schedule M in the pharmaceutical sector?
A) To increase profitability
B) To ensure quality and safety
C) To reduce manufacturing costs
D) To promote exports
Correct Answer: B
Question 2: Which amendment expanded Schedule M in 2005?
A) Quality Control Procedures
B) Requirements of Premises, Plant, and Equipment
C) Personnel Training Guidelines
D) Equipment Maintenance Standards
Correct Answer: B
Question 3: What does Schedule M emphasize for pharmaceutical laboratories?
A) Cost reduction
B) Quality control systems
C) Marketing strategies
D) Global compliance
Correct Answer: B
Question 4: Why was the July 2023 announcement significant for MSMEs?
A) It enabled foreign investment
B) It made Schedule M mandatory
C) It increased production capacity
D) It reduced regulatory scrutiny
Correct Answer: B
Question 5: What is a key requirement for personnel under Schedule M?
A) High salaries
B) Advanced degrees
C) Proper training and hygiene
D) International experience
Correct Answer: C
Question 6: What does Schedule M require in terms of documentation?
A) Minimal records
B) Comprehensive documentation
C) Random checks
D) No documentation
Correct Answer: B
Question 7: What is a consequence of not adhering to Schedule M?
A) Increased production
B) Regulatory penalties
C) Improved public trust
D) Enhanced market reach
Correct Answer: B
Kutos : AI Assistant!